Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

BioHarvest Sciences research shows benefits of Vinia capabilities with blood flow improvement

BioHarvest Sciences research shows benefits of Vinia capabilities with blood flow improvement

BioHarvest Sciences (CSE: BHSC) CEO Ilan Sobel joined Steve Darling from Proactive to share news the company feels their flagship VINIA product is the only dietary supplement available in the US market which can constrict the blood vessel and therefore have the potential for anti-ageing properties.

Sobel telling Proactive a recent blind placebo study showed Vinia both reduced the endothelin 1 enzyme as well as increasing the nitric oxide molecules, in order to increase the dilation of arteries and thereby improve blood flow. Sobel talks about that study and what benefits Vinia can have on the body.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK